Skip to content


Cystagon, Procysbi (cysteamine) is a small molecule pharmaceutical. Cysteamine was first approved as Cystagon on 1994-08-15. It is used to treat cystinosis in the USA. Cystagon's patents are valid until 2036-08-16 (FDA).
Trade Name Cystagon, Procysbi
Common Name Mercaptamine
Indication cystinosis
Drug Class
Get full access now